{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T23:58:27Z","timestamp":1771977507611,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>First-episode psychosis represents a critical period in psychotic disorders, during which timely, appropriate treatment can greatly influence long-term outcomes. Antipsychotics remain the foundation of first-episode psychosis management, yet prescribing patterns vary across settings due to patient characteristics, clinical factors, and resource availability. Although factors influencing antipsychotic choice are increasingly recognized, these have not been examined in the Zambian context. Understanding local prescribing practices is essential to optimizing care and outcomes for individuals with first-episode psychosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe antipsychotic prescription patterns in adults with first-episode psychosis and identify demographic and treatment-related factors associated with second-generation antipsychotic use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional review of medical records was conducted among 213 adults (\u2265\u200918 years) prescribed an antipsychotic for First-episode psychosis between 2019 and 2024 at Chainama Hills College Hospital in Lusaka, Zambia. A data abstraction form captured sociodemographic, clinical, and prescriber information. Descriptive statistics characterized the sample and prescribing patterns, and multivariable logistic regression identified factors independently associated with prescribing second-generation versus first-generation antipsychotics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age of participants was 30.23 years (SD\u2009=\u200911.47), with 72.3% being male, 65.3% single, and 62.0% unemployed. Other psychoses (54.0%) and brief\/acute psychosis (34.7%) were the most common diagnoses in our sample. Chlorpromazine (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200974) and haloperidol (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200975), both first-generation agents, were the most frequently prescribed, followed by risperidone (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200965), a second-generation agent. Overall, first-generation antipsychotics accounted for a slightly larger share of prescriptions. In multivariable logistic regression analysis, females had higher odds of receiving a second-generation antipsychotic prescription (AOR\u2009=\u20097.55, 95% CI 3.27\u201317.41,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), while partial adherence to treatment reduced the odds of second-generation antipsychotic prescription (AOR\u2009=\u20090.39, 95% CI 0.16\u20130.92,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings indicate a relative preference for first-generation antipsychotics, with prescribing influenced by gender and treatment adherence. Prescribing reflects pragmatic, context-driven decision-making shaped by medication availability and affordability in a low-resource setting. This calls for policies that strengthen evidence-based prescribing practices, integrate sex-sensitive and adherence-focused approaches, and improve access to effective antipsychotic options within health systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable. This study is a secondary analysis of de-identified electronic health records and does not constitute a clinical trial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-026-07847-y","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:15:02Z","timestamp":1769764502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antipsychotic prescribing patterns and determinants in first-episode psychosis: a 2019\u20132024 cross-sectional study from Zambia"],"prefix":"10.1186","volume":"26","author":[{"given":"Lihlizulu Thabo","family":"Moyo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6477-0261","authenticated-orcid":false,"given":"Thandiwe Martha","family":"Tembo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6698-815X","authenticated-orcid":false,"given":"Brian","family":"Maila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"7847_CR1","doi-asserted-by":"publisher","first-page":"101677","DOI":"10.1016\/J.AVB.2021.101677","volume":"61","author":"J Del Pozzo","year":"2021","unstructured":"Del Pozzo J, Walsh-Messinger J, Antonius D. The influence of childhood trauma on aggression and violent behavior in first episode psychosis: A critical review. Aggress Violent Beh. 2021;61:101677. https:\/\/doi.org\/10.1016\/J.AVB.2021.101677.","journal-title":"Aggress Violent Beh"},{"key":"7847_CR2","doi-asserted-by":"publisher","unstructured":"Sanjeev KPE. (2024). Psychosis. Encyclopedia of Religious Psychology and Behavior, 1\u201315. https:\/\/doi.org\/10.1007\/978-3-031-38971-9_455-1.","DOI":"10.1007\/978-3-031-38971-9_455-1"},{"issue":"6","key":"7847_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/JAMAPSYCHIATRY.2018.0623","volume":"75","author":"CU Correll","year":"2018","unstructured":"Correll CU, Galling B, Pawar A, Krivko A, Bonetto C, Ruggeri M, Craig TJ, Nordentoft M, Srihari VH, Guloksuz S, Hui CLM, Chen EYH, Valencia M, Juarez F, Robinson DG, Schooler NR, Brunette MF, Mueser KT, Rosenheck RA, Kane JM. Comparison of early intervention services vs treatment as usual for early-Phase psychosis: A systematic Review, Meta-analysis, and Meta-regression. JAMA Psychiatry. 2018;75(6):555\u201365. https:\/\/doi.org\/10.1001\/JAMAPSYCHIATRY.2018.0623.","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"7847_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4088\/JCP.14M09289","volume":"76","author":"JM Kane","year":"2015","unstructured":"Kane JM, Schooler NR, Marcy P, Correll CU, Brunette MF, Mueser KT, Rosenheck RA, Addington J, Estroff SE, Robinson J, Penn DL, Robinson DG. The RAISE early treatment program for first-episode psychosis: background, rationale, and study design. J Clin Psychiatry. 2015;76(3):240\u20136. https:\/\/doi.org\/10.4088\/JCP.14M09289.","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"7847_CR5","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1176\/APPI.AJP.2020.177901","volume":"177","author":"GA Keepers","year":"2020","unstructured":"Keepers GA, Fochtmann LJ, Anzia JM, Benjamin S, Lyness JM, Mojtabai R, Servis M, Walaszek A, Buckley P, Lenzenweger MF, Young AS, Degenhardt A, Hong SH. The American psychiatric association practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry. 2020;177(9):868\u201372. https:\/\/doi.org\/10.1176\/APPI.AJP.2020.177901.","journal-title":"Am J Psychiatry"},{"key":"7847_CR6","doi-asserted-by":"publisher","unstructured":"Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov (N Y). 2013;3(1). https:\/\/doi.org\/10.7916\/D88P5Z71.","DOI":"10.7916\/D88P5Z71"},{"issue":"6","key":"7847_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1017\/S1461145712001277","volume":"16","author":"JP Zhang","year":"2013","unstructured":"Zhang JP, Gallego JA, Robinson DG, Malhotra AK, Kane JM, Correll CU. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2013;16(6):1205\u201318. https:\/\/doi.org\/10.1017\/S1461145712001277.","journal-title":"Int J Neuropsychopharmacol"},{"key":"7847_CR8","unstructured":"Ministry of Health (2022) Treatment Guidelines For Mental Disorders. https:\/\/www.scribd.com\/document\/923187518\/Treatment-Guidelines-for-Mental-Disorders-2022-Ministry-of-Health."},{"key":"7847_CR9","unstructured":"National Institute for Health and Care Excellence. Psychosis and schizophrenia in adults: prevention and management. London: National Institute for Health and Care Excellence; 2014."},{"issue":"3","key":"7847_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/WPS.20060;PAGEGROUP:STRING:PUBLICATION","volume":"12","author":"JM Kane","year":"2013","unstructured":"Kane JM, Kishimoto T, Correll CU. Non-adherence to medication in patients with psychotic disorders: Epidemiology, contributing factors and management strategies. World Psychiatry. 2013;12(3):216\u201326. https:\/\/doi.org\/10.1002\/WPS.20060;PAGEGROUP:STRING:PUBLICATION.","journal-title":"World Psychiatry"},{"issue":"1","key":"7847_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/J.2051-5545.2011.TB00014.X","volume":"10","author":"M De Hert","year":"2011","unstructured":"De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen DAN, Asai I, Detraux J, Gautam S, M\u00f6ller HJ, Ndetei DM, Newcomer JW, Uwakwe R, Leucht S. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry: Official J World Psychiatric Association (WPA). 2011;10(1):52\u201377. https:\/\/doi.org\/10.1002\/J.2051-5545.2011.TB00014.X.","journal-title":"World Psychiatry: Official J World Psychiatric Association (WPA)"},{"key":"7847_CR12","doi-asserted-by":"publisher","unstructured":"Hoekstra S, Bartz-Johannessen C, Sinkeviciute I, Reitan SK, Kroken RA, L\u00f8berg EM, Larsen TK, Rettenbacher M, Johnsen E, Sommer IE. Sex differences in antipsychotic efficacy and side effects in schizophrenia spectrum disorder: results from the BEST INTRO study. NPJ Schizophr. 2021;7(1). https:\/\/doi.org\/10.1038\/S41537-021-00170-3.","DOI":"10.1038\/S41537-021-00170-3"},{"key":"7847_CR13","doi-asserted-by":"publisher","unstructured":"Seeman MV. The pharmacodynamics of antipsychotic drugs in women and men. Front Psychiatry. 2021;12. https:\/\/doi.org\/10.3389\/FPSYT.2021.650904.","DOI":"10.3389\/FPSYT.2021.650904"},{"key":"7847_CR14","doi-asserted-by":"publisher","unstructured":"Lugtenberg M, Zegers-Van Schaick JM, Westert GP, Burgers JS. Why don\u2019t physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners. Implement Sci. 2009;4(1). https:\/\/doi.org\/10.1186\/1748-5908-4-54.","DOI":"10.1186\/1748-5908-4-54"},{"issue":"4","key":"7847_CR15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/schbul\/sbv107","volume":"42","author":"V Patel","year":"2015","unstructured":"Patel V. Universal health coverage for schizophrenia: a global mental health priority. Schizophr Bull. 2015;42(4):885\u201390. https:\/\/doi.org\/10.1093\/schbul\/sbv107.","journal-title":"Schizophr Bull"},{"issue":"6","key":"7847_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1017\/S2045796016000548","volume":"25","author":"B Saraceno","year":"2016","unstructured":"Saraceno B, Barbui C. Global mental health: Achievements, concerns and (unanswered) questions. Epidemiol Psychiatric Sci. 2016;25(6):493\u20134. https:\/\/doi.org\/10.1017\/S2045796016000548.","journal-title":"Epidemiol Psychiatric Sci"},{"key":"7847_CR17","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1017\/S2045796022000087","volume":"31","author":"B Todesco","year":"2022","unstructured":"Todesco B, Ostuzzi G, Barbui C. Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level. Epidemiol Psychiatric Sci. 2022;31:e22. https:\/\/doi.org\/10.1017\/S2045796022000087.","journal-title":"Epidemiol Psychiatric Sci"},{"issue":"4","key":"7847_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/2045125312474019","volume":"3","author":"K Higashi","year":"2013","unstructured":"Higashi K, Medic G, Littlewood KJ, Diez T, Granstr\u00f6m O, de Hert M. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Therapeutic Adv Psychopharmacol. 2013;3(4):200\u201318. https:\/\/doi.org\/10.1177\/2045125312474019.","journal-title":"Therapeutic Adv Psychopharmacol"},{"key":"7847_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/PROM.S42735","volume":"5","author":"PM Haddad","year":"2014","unstructured":"Haddad PM, Brain C, Scott J. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat Outcome Measures. 2014;5:43\u201362. https:\/\/doi.org\/10.2147\/PROM.S42735.","journal-title":"Patient Relat Outcome Measures"},{"key":"7847_CR20","doi-asserted-by":"publisher","unstructured":"Eloff I, Esterhuysen W, Odayar K. Antipsychotic use in a resource-limited setting: findings in an Eastern Cape psychiatric hospital. S Afr J Psychiatr. 2017;23(1). https:\/\/doi.org\/10.4102\/SAJPSYCHIATRY.V23I0.1093.","DOI":"10.4102\/SAJPSYCHIATRY.V23I0.1093"},{"issue":"1","key":"7847_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/JAMPS\/2018\/40478","volume":"19","author":"PO Onah","year":"2018","unstructured":"Onah PO, Abdulmalik A, Kaigamma AY. Antipsychotic drugs prescription pattern among patients with schizophrenia in a federal neuropsychiatric hospital Maiduguri, North East Nigeria. J Adv Med Pharm Sci. 2018;19(1):1\u20138. https:\/\/doi.org\/10.9734\/JAMPS\/2018\/40478.","journal-title":"J Adv Med Pharm Sci"},{"issue":"1","key":"7847_CR22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s13104-019-4398-6","volume":"12","author":"I Chikowe","year":"2019","unstructured":"Chikowe I, Domingo M, Mwakaswaya V, Parveen S, Mafuta C, Kampira E. Adverse drug reactions experienced by out-patients taking chlorpromazine or haloperidol at Zomba mental Hospital, Malawi. BMC Res Notes. 2019;12(1):376. https:\/\/doi.org\/10.1186\/s13104-019-4398-6.","journal-title":"BMC Res Notes"},{"key":"7847_CR23","doi-asserted-by":"publisher","unstructured":"Mayer J, Vasic N, Wolf V, Steiner I, Klein V, Fritz M, Rothe P, Streb J, Dudeck M. Gender differences in the psychopharmacological treatment of forensic in-patients with schizophrenia. Front Psychiatry. 2022;13. https:\/\/doi.org\/10.3389\/FPSYT.2022.907123.","DOI":"10.3389\/FPSYT.2022.907123"},{"key":"7847_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jad.2024.02.038","volume":"352","author":"M Ercis","year":"2024","unstructured":"Ercis M, Sanchez-Ruiz JA, Webb LM, Solares-Bravo M, Betcher HK, Moore KM, Frye MA, Veldic M, Ozerdem A. Sex differences in effectiveness and adverse effects of mood stabilizers and antipsychotics: A systematic review. J Affect Disord. 2024;352:171\u201392. https:\/\/doi.org\/10.1016\/j.jad.2024.02.038.","journal-title":"J Affect Disord"},{"issue":"10","key":"7847_CR25","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/S40263-025-01218-Z","volume":"39","author":"X Lin","year":"2025","unstructured":"Lin X, Siafis S, Tian J, Wu H, Qin M, Correll CU, Schneider-Thoma J, Leucht S. Antipsychotic-Related prolactin changes: A systematic review and Dose-Response Meta-analysis. CNS Drugs. 2025;39(10):937\u201347. https:\/\/doi.org\/10.1007\/S40263-025-01218-Z.","journal-title":"CNS Drugs"},{"key":"7847_CR26","doi-asserted-by":"publisher","unstructured":"Santangelo G, Gnazzo M, Baldini V, De Ronchi D, Carotenuto M, Fiorillo A, D\u2019Agostino A. Unraveling the gender divide: a systematic review of gender-specific differences at the first episode of psychosis. Psychiatry Res. 2026;356. https:\/\/doi.org\/10.1016\/J.PSYCHRES.2025.116914.","DOI":"10.1016\/J.PSYCHRES.2025.116914"},{"issue":"4","key":"7847_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/01.jcp.0000085413.08426.41","volume":"23","author":"CR Dolder","year":"2003","unstructured":"Dolder CR, Lacro JP, Leckband S, Jeste DV. Interventions to improve antipsychotic medication adherence: review of recent literature. J Clin Psychopharmacol. 2003;23(4):389\u201399. https:\/\/doi.org\/10.1097\/01.jcp.0000085413.08426.41.","journal-title":"J Clin Psychopharmacol"},{"key":"7847_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/00912174241310091","author":"A Meyer","year":"2024","unstructured":"Meyer A, Truman K, Totlani J, William C, Brown H, Shah S, Hirsch D, Salem M, Chang T, Abdelsalam R, Renteria S, Murphy N, Hedrick R, Danovitch I, Pechnick RN, IsHak WW. Systematic review of long-acting injectable antipsychotic medications approved from 2008 to October 2024 and agents in phase 3. Int J Psychiatry Med. 2024. https:\/\/doi.org\/10.1177\/00912174241310091.","journal-title":"Int J Psychiatry Med"},{"key":"7847_CR29","doi-asserted-by":"publisher","unstructured":"Beyene MG, Teferra S, Fenta TG. Non-adherence and predictors in patients with schizophrenia on second generation antipsychotics at Amanuel Mental Specialized Hospital, Ethiopia. PLoS ONE. 2025;20(3). https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0314403.","DOI":"10.1371\/JOURNAL.PONE.0314403"},{"issue":"2","key":"7847_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.17772\/gp\/2002","volume":"86","author":"J Bartkowiak-Wieczorek","year":"2015","unstructured":"Bartkowiak-Wieczorek J, Wolski H, Bogacz A, Kujawski R, Ozarowski M, Majchrzycki M, Seremak-Mrozikiewicz A. Gender-specific implications for Pharmacology in childbearing age and in postmenopausal women. Ginekologia Polska. 2015;86(2):143\u20139. https:\/\/doi.org\/10.17772\/gp\/2002.","journal-title":"Ginekologia Polska"},{"issue":"8","key":"7847_CR31","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1176\/appi.ajp.161.8.1324","volume":"161","author":"MV Seeman","year":"2004","unstructured":"Seeman MV. Gender differences in the prescribing of antipsychotic drugs. Am J Psychiatry. 2004;161(8):1324\u201333. https:\/\/doi.org\/10.1176\/appi.ajp.161.8.1324.","journal-title":"Am J Psychiatry"},{"key":"7847_CR32","doi-asserted-by":"publisher","unstructured":"Seeman MV. Men and women respond differently to antipsychotic drugs. Neuropharmacology. 2020;163. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.05.008.","DOI":"10.1016\/j.neuropharm.2019.05.008"},{"key":"7847_CR33","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2147\/RMHP.S409929","volume":"16","author":"H Fikreselam","year":"2023","unstructured":"Fikreselam H, Mekdes S, Hana B. Availability, price and affordability of psychotropic medicines in addis Ababa, Ethiopia. Risk Manage Healthc Policy. 2023;16:957\u201370. https:\/\/doi.org\/10.2147\/RMHP.S409929.","journal-title":"Risk Manage Healthc Policy"},{"key":"7847_CR34","doi-asserted-by":"publisher","unstructured":"Cashin C, Gatome-Munyua A. The strategic health purchasing progress tracking framework: a practical approach to describing, assessing, and improving strategic purchasing for universal health coverage. Health Syst Reform. 2022;8(2). https:\/\/doi.org\/10.1080\/23288604.2022.2051794.","DOI":"10.1080\/23288604.2022.2051794"},{"key":"7847_CR35","doi-asserted-by":"publisher","unstructured":"Ezenduka C, Obikeze E, Uzochukwu B, Onwujekwe O. Examining healthcare purchasing arrangements for strategic purchasing in Nigeria: a case study of the Imo State Healthcare system. Health Res Policy Syst. 2022;20(1). https:\/\/doi.org\/10.1186\/s12961-022-00844-z.","DOI":"10.1186\/s12961-022-00844-z"},{"key":"7847_CR36","doi-asserted-by":"publisher","unstructured":"Gatome-Munyua A, Sieleunou I, Barasa E, Ssengooba F, Issa K, Musange S, Osoro O, Makawia S, Boyi-Hounsou C, Amporfu E, Ezenwaka U. Applying the strategic health purchasing progress tracking framework: lessons from nine African countries. Health Syst Reform. 2022;8(2). https:\/\/doi.org\/10.1080\/23288604.2022.2051796.","DOI":"10.1080\/23288604.2022.2051796"},{"key":"7847_CR37","doi-asserted-by":"publisher","unstructured":"Kiendr\u00e9b\u00e9ogo JA, De Allegri M, Van Damme W, Meessen B. Using a policy learning lens to understand health financing policy outcomes: the case of translating strategic health purchasing into policy and practice in Burkina Faso. BMJ Glob Health. 2024;9(11). https:\/\/doi.org\/10.1136\/bmjgh-2024-015488.","DOI":"10.1136\/bmjgh-2024-015488"},{"key":"7847_CR38","doi-asserted-by":"publisher","unstructured":"Maiba J, Singh NS, Cassidy R, Mtei G, Borghi J, Kapologwe NA, Binyaruka P. Assessment of strategic healthcare purchasing and financial autonomy in Tanzania: the case of results-based financing and health basket fund. Front Public Health. 2023;11. https:\/\/doi.org\/10.3389\/fpubh.2023.1260236.","DOI":"10.3389\/fpubh.2023.1260236"},{"key":"7847_CR39","doi-asserted-by":"publisher","unstructured":"Matovu F, Gatome-Munyua A, Sebaggala R. Has strategic purchasing led to improvements in health systems? A narrative review of literature on strategic purchasing. Health Syst Reform. 2022;8(2). https:\/\/doi.org\/10.1080\/23288604.2022.2151698.","DOI":"10.1080\/23288604.2022.2151698"},{"issue":"1","key":"7847_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13561-021-00346-8","volume":"11","author":"C Mbachu","year":"2021","unstructured":"Mbachu C, Okeke C, Obayi C, Gatome-Munyua A, Olalere N, Ogbonna I, Uzochukwu B, Onwujekwe O. Supporting strategic health purchasing: a case study of annual health budgets from general tax revenue and social health insurance in abia state, Nigeria. Health Econ Rev. 2021;11(1):47. https:\/\/doi.org\/10.1186\/s13561-021-00346-8.","journal-title":"Health Econ Rev"},{"key":"7847_CR41","doi-asserted-by":"publisher","unstructured":"Onwujekwe O, Mbachu CO, Okeke C, Ezenwaka U, Ogbuabor D, Ezenduka C. Strategic health purchasing in Nigeria: exploring the evidence on health system and service delivery improvements. Health Syst Reform. 2022;8(2). https:\/\/doi.org\/10.1080\/23288604.2022.2111785.","DOI":"10.1080\/23288604.2022.2111785"},{"key":"7847_CR42","doi-asserted-by":"publisher","unstructured":"Semahegn A, Torpey K, Manu A, Assefa N, Tesfaye G, Ankomah A. Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis. Syst Rev. 2020;9(1). https:\/\/doi.org\/10.1186\/S13643-020-1274-3.","DOI":"10.1186\/S13643-020-1274-3"},{"key":"7847_CR43","doi-asserted-by":"publisher","unstructured":"Ali S, Sethi A, Soltani A, Nazar Z. Impact of continuing professional development (CPD) on patient outcomes: a systematic scoping review. BMC Med Educ. 2025;25(1). https:\/\/doi.org\/10.1186\/S12909-025-07883-4.","DOI":"10.1186\/S12909-025-07883-4"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-07847-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07847-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07847-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T23:04:01Z","timestamp":1771974241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-07847-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7847"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-07847-y","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used de-identified electronic health record data and involved no direct contact or interaction with patients. As such, informed consent for participation was waived. The research protocol, including the waiver of informed consent, was reviewed and approved by the University of Zambia Biomedical Research Ethics Committee (UNZABREC Approval Number: REF. No. 5903\u2009\u2212\u20092024), with additional authorization from the National Health Research Authority (NHRA) and institutional consent from the management of Chainama Hills College Hospital. All study procedures were conducted in accordance with the ethical principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable; the study involved no collection or use of personal health identifiers.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"208"}}